Athyrium Funds GP Holdings LLC
Related Filers (22)
- Ferrell Jeffrey (8)
- BIORA THERAPEUTICS, INC. (7)
- NB Alternatives Holdings LLC (5)
- NB Alternatives Advisers LLC (5)
- NB Alternatives GP Holdings LLC (5)
- Athyrium Capital Holdings, LLC (5)
- Athyrium Capital Management, LP (5)
- Athyrium Opportunities Advisers LLC (5)
- Athyrium Opportunities III Acquisition LP (5)
- Societal CDMO, Inc. (2)
- Athyrium Opportunities Associates III LP (2)
- Athyrium Opportunities III Acquisition 2 LP (2)
- Athyrium Opportunities Associates III GP LLC (2)
- Athyrium Opportunities Associates Co-Invest LLC (2)
- Athyrium Opportunities 2020 LP (2)
- Athyrium Opportunities III Co-Invest 1 LP (2)
- Athyrium Opportunities Associates IV LP (1)
- Athyrium Opportunities IV Acquisition 2 LP (1)
- Athyrium Opportunities Associates IV Co-Invest LLC (1)
- Athyrium Opportunities Associates IV GP LLC (1)
- RVL Pharmaceuticals plc (1)
- Athyrium Opportunities IV Co-invest 2 LP (1)
- Show More ...
Ownership (10)
SC 13G/A
Tuesday, 2/14/2023
Societal CDMO, Inc.: Major Shareholders
4
Thursday, 1/5/2023
BIORA THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 11/14/2022
BIORA THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Friday, 8/12/2022
RVL Pharmaceuticals plc: Initial statement of beneficial ownership of securities
4
Monday, 6/14/2021
PROGENITY, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/3/2021
PROGENITY, INC.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/26/2021
Recro Pharma, Inc.: Major Shareholders
4
Wednesday, 12/9/2020
PROGENITY, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/25/2020
PROGENITY, INC.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/18/2020
PROGENITY, INC.: Initial statement of beneficial ownership of securities